Guangdong Jiaying Pharmaceutical Co., Ltd (SZSE: 002198)
Health Care · Pharmaceuticals · CN
CN¥3.58
-0.83% today · -42.4% 1Y
Guangdong Jiaying Pharmaceutical Co., Ltd (SZSE: 002198) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $265.31M and employs 594 people.
Over the last twelve months the share price has lost 42.4%, trading between 2.90 and 8.43.
Tweenvest scores Guangdong Jiaying Pharmaceutical Co., Ltd across four factors: quality 72/100, value 71/100, growth 8/100. Its strongest factor is quality.
002198 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $265.31M
- Revenue (TTM)
- $51.61M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- -0.03
- 52-week high
- CN¥8.43
- 52-week low
- CN¥2.90
- Avg volume (3M)
- —
- Shares outstanding
- 497.11M
- Employees
- 594
- Next earnings
- —
About Guangdong Jiaying Pharmaceutical Co., Ltd
Guangdong Jiaying Pharmaceutical Co., Ltd. is engaged in the comprehensive process of researching, developing, manufacturing, and marketing traditional Chinese medicines. Its operations span a vast international territory, encompassing Mainland China, Taiwan, Hong Kong, Macao, Southeast Asia, Europe, and the United States. The company primarily offers therapeutic solutions for a variety of health issues, such as throat conditions, common colds, orthopedic ailments, rheumatic diseases, gynecological disorders, conditions requiring heat-clearing, and gastrointestinal problems. These medical preparations are provided in numerous formats, including powders, tablets, capsules, granules, and pills. The distribution of its product line occurs through both independent agencies and direct sales points. The firm's operational hub is situated in Meizhou, China.
- ISIN
- CNE1000008P1
- Founded
- 2003
- Listed since
- Dec 19, 2007
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| EyePoint, Inc.NasdaqGM: EYPT | $280.19M | $3.46 | +6.46% |
| Pharmasaga Co. Ltd.TPEX: 7878 | $279.83M | NT$166.50 | -8.77% |
| Hikal LimitedBSE: 524735 | $279.37M | Rs218.15 | +0.09% |
| Duopharma Biotech BerhadKLSE: DPHARMA | $268.43M | RM1.14 | -4.20% |
| Starpharma Holdings LimitedASX: SPL | $265.14M | AU$0.80 | -4.76% |
| Hunan Nucien Pharmaceutical Co., Ltd.SHSE: 688189 | $259.64M | CN¥6.44 | -0.62% |
| Celon Pharma S.A.WSE: CLN | $258.98M | zł18.68 | -0.11% |
| AFT Pharmaceuticals LimitedNZSE: AFT | $257.17M | NZ$4.37 | -0.46% |
Figures last refreshed Oct 4, 2026.